- Home
- RGC
as 07-11-2025 3:36pm EST
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
| Founded: | 2014 | Country: | Hong Kong |
| Employees: | N/A | City: | N/A |
| Market Cap: | 38.6B | IPO Year: | 2021 |
| Target Price: | N/A | AVG Volume (30 days): | 2.8M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.01 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.08 - $83.60 | Next Earning Date: | 06-30-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Regencell Bioscience Holdings Limited News
RGC Breaking Stock News: Dive into RGC Ticker-Specific Updates for Smart Investing
GuruFocus.com
15 days ago
Regencell's 82,000% Surge: The $33 Billion Stock Rally That Nobody Can Explain
Bloomberg
15 days ago
Mystery $33 Billion Medicine Fortune Collapses in Days
MT Newswires
17 days ago
Top Premarket Gainers
MT Newswires
19 days ago
Top Premarket Decliners
Simply Wall St.
22 days ago
Regencell Bioscience Holdings (NasdaqCM:RGC) Announces 38:1 Stock Split Effective June 2025
GuruFocus.com
25 days ago
The 46,000% Biotech Rocket: How a No-Revenue Stock Hit $30 Billion
Yahoo Finance Video
25 days ago
Silver's rise, Reddit's AI ad tools, Regencell Bioscience surges
MT Newswires
25 days ago
Top Premarket Gainers
Compare RGC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "RGC Regencell Bioscience Holdings Limited - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.